http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010043090-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010043090-A |
| titleOfInvention | NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| abstract | The present invention provides a novel polypeptide of human, cDNA encoding the polypeptide andn n n It is about the use.n n n Since the polypeptide of the present invention has an effect of inhibiting the proliferation of vascular smooth muscle cells, it is applicable to the treatment of diseases involving proliferation of abnormal smooth muscle, such as atherosclerosis and myoma. In addition, hematopoietic cell control activity, tissue production / restoration activity, actibin / inhibin activity, chemotaxis / chemotactic activity, coagulation and thrombus activity, receptor / ligand activity, etc. I find it useful. |
| priorityDate | 1998-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 562.